These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Update on indices of disease activity in systemic sclerosis. Hudson M; Steele R; ; Baron M Semin Arthritis Rheum; 2007 Oct; 37(2):93-8. PubMed ID: 17363039 [TBL] [Abstract][Full Text] [Related]
9. The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Valentini G; Iudici M; Walker UA; Jaeger VK; Baron M; Carreira P; Czirják L; Denton CP; Distler O; Hachulla E; Herrick AL; Kowal-Bielecka O; Pope J; Müller-Ladner U; Riemekasten G; Avouac J; Frerix M; Jordan S; Minier T; Siegert E; Ong VH; Vettori S; Allanore Y Ann Rheum Dis; 2017 Jan; 76(1):270-276. PubMed ID: 27621285 [TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of juvenile systemic sclerosis in Japanese. Murata M; Sato S; Komura K; Shirasaki F; Hasegawa M; Takehara K J Rheumatol; 2005 Sep; 32(9):1850-2. PubMed ID: 16142890 [No Abstract] [Full Text] [Related]
12. The clinical characteristics of juvenile-onset systemic sclerosis in Japanese patients. Hatta Y; Hasegawa M; Matsushita T; Hamaguchi Y; Fujimoto M; Takehara K Mod Rheumatol; 2014 Mar; 24(2):377-9. PubMed ID: 24593219 [No Abstract] [Full Text] [Related]
13. Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis. Smith V; Riccieri V; Pizzorni C; Decuman S; Deschepper E; Bonroy C; Sulli A; Piette Y; De Keyser F; Cutolo M J Rheumatol; 2013 Dec; 40(12):2023-8. PubMed ID: 24128778 [TBL] [Abstract][Full Text] [Related]
14. Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale. Geirsson AJ; Wollheim FA; Akesson A Ann Rheum Dis; 2001 Dec; 60(12):1117-22. PubMed ID: 11709453 [TBL] [Abstract][Full Text] [Related]
15. Consensus-based recommendations for the management of juvenile systemic sclerosis. Foeldvari I; Culpo R; Sperotto F; Anton J; Avcin T; Baildam E; Boros C; Chaitow J; Constantin T; Kasapcopur O; Knupp Feitosa de Oliveira S; Pilkington C; Toplak N; van Royen A; Saad Magalhaes C; Vastert SJ; Wulffraat N; Zulian F Rheumatology (Oxford); 2021 Apr; 60(4):1651-1658. PubMed ID: 33147624 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohort. Foeldvari I; Nihtyanova SI; Wierk A; Denton CP J Rheumatol; 2010 Nov; 37(11):2422-6. PubMed ID: 20843905 [TBL] [Abstract][Full Text] [Related]
17. Acro-osteolysis as an indicator of severity in systemic sclerosis. Arana-Ruiz JC; Amezcua-Guerra LM Reumatol Clin; 2016; 12(5):263-6. PubMed ID: 26746600 [TBL] [Abstract][Full Text] [Related]
18. Assessment of damage and activity in systemic sclerosis. Medsger TA Curr Opin Rheumatol; 2000 Nov; 12(6):545-8. PubMed ID: 11092206 [TBL] [Abstract][Full Text] [Related]